Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as $54.75 and last traded at $54.70, with a volume of 2168 shares. The stock had previously closed at $54.06.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada upgraded shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a research note on Friday, May 2nd.
Check Out Our Latest Report on SDZNY
Sandoz Group Trading Up 1.4%
The company has a quick ratio of 0.79, a current ratio of 1.24 and a debt-to-equity ratio of 0.57. The business's fifty day moving average is $49.96 and its 200-day moving average is $45.63.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
